久久一区二区三区四区_欧美高清dvd_日韩欧美在线看_国产精品欧美一区二区_av天天看_欧美精品免费观看二区

國藥一致,Sinopharm Accord,  
國藥集團一致藥業股份有限公司（簡稱國藥一致）是集醫藥研發、制藥工業、藥品分銷、醫藥物流為一體的綜合性醫藥上市公司（A股000028，B股200028），是中國醫藥集團、國藥控股在中國南區的核心企業，承擔著國家、省、市政府藥品特儲任務。國藥一致擁有工業和分銷兩大業態，屬下企業共有32家，分布于廣東、廣西、江蘇等地區。截至目前，企業銷售規模超200億元，擁有員工4100多人。
　　國藥一致制藥工業集產品研發、原料與制劑生產、市場營銷于一體，產品主要覆蓋抗感染、呼吸系統用藥、消化系統用藥、心腦血管用藥以及中成藥、保健品等領域。其全資企業深圳致君制藥有限公司、國藥控股深圳中藥有限公司，蘇州致君萬慶藥業有限公司，參股企業深圳萬樂藥業有限公司均為國家級高新技術企業，重點品種頭孢呋辛、頭孢克肟、頭孢西丁、頭孢米諾、頭孢哌坦等原料或制劑在細分市場處于領先地位，并擁有7個單品銷售超億元。其中，深圳致君制藥有限公司是國內首家自主產品注冊通過歐盟GMP認證的頭孢粉針制劑生產廠商，位列中國制藥工業企業50強。
　　國藥一致藥品分銷業務位居廣東、廣西榜首，名列中國醫藥商業20強，下屬企業29家，分布于深圳、廣州、東莞、佛山、湛江、梅州、肇慶、惠州、南寧、柳州、江門、桂林、玉林、百色等兩廣區域。分銷業務涵蓋醫院純銷、商業調撥、藥品快批及終端配送等，擁有完善的全國商業網絡和深度滲透的南區終端市場網絡，擁有華南地區自動化程度最高、服務能力最強的專業醫藥物流中心，也是華南地區首家獲批第三方醫藥物流資質的企業。目前，國藥一致分銷全力打造智慧型供應鏈新的分銷商業模式，已在廣州、梅州等地開設6家DTC專業藥房，并進入B2B藥品電子商務領域。
　　未來，國藥一致將以內涵增長為主，由關注規模增長轉變為質量效益領先；充分內部挖潛和資源整合；創新產品技術，創新商業模式，創新服務水平；積極發展新業務，堅持科工貿協同發展，成為具有國際競爭力的醫藥健康產品和服務提供商。
　　

愿景：以世界優秀企業為標桿，做中國醫藥企業的典范；
使命：生命與健康的守護者；
地址：深圳市福田區八卦四路15號一致藥業大廈

Brief introduction to China National Accord Medicines Corporation., Ltd
　 China National Accord Medicines Corporation., Ltd (short as Sinopharm Accord) is a comprehensive pharmaceutical publicly listed company (A Share: 000028, B Share: 200028) with four businesses—medicine distribution, pharmaceutical industry and pharmaceutical logistic. Our subordinate enterprises are distributed in Guangdong and Guangxi. Up to the end of 2007, the total asset of Sinopharm Accord amounts to 2,900,000,000 yuan and the annual sale exceeds 8,000,000,000 yuan.
　　The total employees in Sinopharm Accord reach 4,500. In 2004, the company transformed from Shenzhen state-owned enterprise into a member of China National Pharmaceutical Group Corporation. Sinopharm Accord promotes “Care for life, attend to health” as its enterprise concept and adheres to the Scientific development View as development by customer and market as orientation and organizational capability as its basis. With strategies of Strategic Drive and Integration Operation, Accordance Pharm brings along internal restructure, strategic adjustment, and alteration of marketing strategy. Deeper fine management has brought advance of three competitive edges “efficiency, variety and client” and improvement in three comprehensive abilities “operation, payoff and growth”.
　In the management control mode of integrated operation of the company, functions of headquarter is exercised by the four centers--operation management, finance management, human resource and administrative management. Management functions are exercised by the four business divisions—distribution division, pharmaceutical division, chain store division, logistics division.
　Sinopharm Holding Guangzhou Co., Ltd is the core enterprise of Distribution Division. With integrated operation, the division maximizes resource sharing such as verity, information, capital, logistic storage, and forms “Large Southern Region” platform of the medical & pharmaceutical business field in South China.
　Shenzhen Zhijun Pharmaceutical Co., Ltd.is the core enterprise of Pharmaceutical Division, the subsidiary of China National Pharmaceutical Group Corporation. With the advantage of the scientific research cooperation with Sichuan Industrial Institute of Antibiotics, the division has extended product lines, and developed relevant corollary equipment for the production of crude drug. With construction of an integrative industrial chain, the division enters into new field under appropriate situation, and quickens its deploitation of international mainstream marketplace. Accordance Pharm strives to become one of the top 20 of Chinese pharmaceutical industry in five years.
　Accordance Pharm Chain Store Co., Ltd is the large operation platform of Chain Store Division. Through connection with asset relationship, Accordance Pharm Chain Store will gradually shape itself into a pattern of unification between stock structure of chain type and management structure. The division aims to achieve a scale of 600 chain stores to reveal the brand influence of Accordance Drug Store and the power of terminal control in 2010.
　With support of the national integrated logistics distribution network of Sinopharm Holding and regional logistics warehouse with perfect corollary equipment, Logistics Division is devoted to meeting the requirement that the client network distribution be multi-terminal and deep coverage in all regions, strives to provide the customers solution of integrative logistic distribution, and develops to be the third logistic company in the pharmaceutical circulation domain.
　The prospective Accordance Pharm will continue to commit itself to the business restructuring and capital strategic operation and aims to become excellent public company in the China Medical and Pharmaceutical Industry and to become the first medical and pharmaceutical brand in South China.